| http://www.w3.org/ns/prov#value | - In short, the FDA???s rule is a poor tool for keeping generic drug labels up-to-date, and it will come at a significant cost to consumers.Better Policy Options for Updating Generic Drug LabelsThere are far more effective and efficient ways of keeping generic drug labels up-to-date and ensuring that generic firms continue to engage in an equivalent or higher level of postmarket safety surveillance.
|
